JS

Jann Skinner

Telix Pharmaceuticals Limited | Non-Executive Director
Ms. Skinner has financial acumen, accounting and auditing expertise, with understanding of risk management compliance frameworks and control oversight. Her listed company experience and expertise in capital management and corporate development enable her to challenge management constructively. Ms. Skinner has experience in auditing, accounting and in the insurance industry. She was a partner of PricewaterhouseCoopers for 17 years before retiring in 2004. She has served as a Director of Create Foundation Limited (since June 2004). She previously also served as a Director of HSBC Bank Australia Limited (from April 2017 to April 2023) and as an independent Non-Executive Director of QBE Insurance Group Limited (from October 2014 to May 2024). She is chair of Risk Commitee and member of People, Culture Committee and Disclosure Commitee.

Company and Role

Company
Title
Tenure
Since
TLX
Telix Pharmaceuticals Limited
  • Non-Executive Director
6yrs, 11mthJun 2018

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
TLX
Telix Pharmaceuticals Limited
31/12/24N/A595,000N/AN/A
30/12/23N/A70,000N/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
TLX
Telix Pharmaceuticals Limited
09/11/22
Issued
495,000$1.090$539,550Exercise of options
TLX
Telix Pharmaceuticals Limited
09/11/22
Exercise
495,000$1.090$539,550Exercise of options
08/03/21
Buy
6,005$9.500$57,047On-market trade
20/05/20
Issued
3,995$7.510$30,002Participation in share purchase plan
11/03/20
Buy
10,000$11.100$111,000On-market trade